跳至主要内容
临床试验/NCT05544058
NCT05544058已完成不适用

Retrospective Non-interventional Study of Stiripentol Use in Dravet Patients in the USA

Biocodex1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2022年4月27日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Biocodex
入组人数
100
试验地点
1
主要终点
management of the Dravet syndrome

研究概览

简要总结

The present study aims to collect data regarding the history of the disease, previous and current treatments, and the clinical status of Dravet patients during the 3 months prior to stiripentol initiation, the first 3 months on stiripentol and the last 3 months on stiripentol (irrespective of stiripentol discontinuation).

研究设计

研究类型
Observational
观察模型
Other
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients diagnosed with Dravet syndrome
  • Treated with stiripentol for a minimum of 3 months in routine practice

排除标准

  • 未提供

结局指标

主要结局

management of the Dravet syndrome

时间窗: through study completion, an average of 1 year

Patient Information History of the Disease Clinical status of the patient during the 3 months preceding stiripentol treatment initiation Clinical status of the patient at stiripentol initiation Clinical status of the patient during the first 3 months of stiripentol treatment Clinical status of the patient during the last 3 months of stiripentol treatment Evolution on stiripentol

次要结局

  • Better detection of the Dravet syndrome(through study completion, an average of 1 year)

研究者

发起方
Biocodex
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验